Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
about
Plasmid-determined AmpC-type beta-lactamases.Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymesStructure of AmpC β-lactamase (AmpCD) from anEscherichia coliclinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helixStructural analysis of the Asn152Gly mutant of P99 cephalosporinaseNew disturbing trend in antimicrobial resistance of gram-negative pathogensGenetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenesExtended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece.Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.Plasmid-borne AmpC beta-lactamases.Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.Kinetics of the Interaction between BAL29880 and LK157 and the Class C β-Lactamase CHE-1New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.Extended-spectrum cephalosporinases: structure, detection and epidemiology.Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamaseAmpC beta-lactamases.AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to Carbapenems.Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime.Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolateCharacterization of IS26-composite transposons and multidrug resistance in conjugative plasmids from Enterobacter cloacae.Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animalsEstablishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.Exact location of the region responsible for the extended substrate spectrum in class C beta-lactamases.Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
P2860
Q24535748-2C944FCD-884A-4D65-A614-02596E5BDC84Q27642738-595E9C46-0A4D-4DDB-84BE-97EEC8BDC35BQ27655673-FE1BD178-E9BB-4390-A1D4-94F3BA12F743Q27682153-3149FCCA-D598-45CB-AAA4-A53FC6F93CE3Q33422956-61CCA643-3F5E-4FFF-B047-A09CC4BB16CAQ33768904-DAF475D3-E4CF-4CBC-B5E8-3F0FF1774226Q33857230-09090BAD-30C8-4192-B238-02C5DE5C58C2Q34110075-5E2F2073-6030-465B-B988-8A6E14AD0DD0Q34352060-F2C8D063-5231-474C-A43B-C14161E5959AQ34776284-C2F51B8E-FCA0-40A3-B986-AF22475311C0Q35005118-C50F12D2-0F43-4318-8CF1-C8AE11121B28Q35007624-4D603997-F0E0-4167-A1F0-F6FAA35DA4EFQ35124477-C1C62173-7943-43E4-BD95-ACBE02462A5FQ35139714-7D4B9848-D0B7-4152-BC86-07DDB7700D94Q35806387-E591CE47-B9BC-4291-A56E-9151215FD856Q36290815-D5559920-7073-4D1D-BE7C-CCE21BF32D0FQ36491987-390C843A-B83C-43B4-9F19-9D61BD5C68ECQ36644853-71779148-2111-403E-BAA8-6C27601FCD43Q36895636-31C07EEE-E9D5-4E58-8986-FFD31839621EQ36895772-7D487016-2E4C-4E36-8BBA-C7902B180611Q37144879-DBF5B7ED-5B93-43D8-8012-C582A78FB7F7Q37247631-1DAC85FD-C30F-412D-8F9C-6D5FCF8FA034Q37366249-F81A8029-B86F-4F6D-8180-EBB052FEDD99Q37568397-3913711E-757C-4E27-9F65-C567065041A5Q38857234-236A1045-52FC-4FA1-A2E6-CCF658186556Q39516180-165A3EE4-6F20-490F-8D73-3C1C652B895BQ39651911-FE4F7AA2-5F59-4AFA-95C0-2A27D8C8E9B6Q40622081-582B1932-5AA6-499A-BCF7-D7DF12DA09A9Q41083494-44FDBBA4-C679-4E7F-98A4-36D49D3DE7F5Q41474257-A022892C-2053-46DD-AB5F-5650A312CB77Q41547467-9C642156-90E0-40A6-BCA2-BB8E61A13CBFQ41766424-E2BDBE8F-3124-4E96-AAF6-E96941322192Q41832354-EFF2B822-636E-4DCF-8EF0-80C38442FDF0Q42627749-E3B9070A-B954-4DFF-9A72-8F313F791346Q43128351-118C5D35-B69B-4284-A5AB-6F27E311F026Q53566414-4F0AC462-6B39-4FF1-A3FE-AD61E9CFB2E9Q54571557-D14F56AD-E62E-4FA4-B2C0-46201DB753D0
P2860
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Extension of resistance to cef ...... cter cloacae clinical isolate.
@ast
Extension of resistance to cef ...... cter cloacae clinical isolate.
@en
type
label
Extension of resistance to cef ...... cter cloacae clinical isolate.
@ast
Extension of resistance to cef ...... cter cloacae clinical isolate.
@en
prefLabel
Extension of resistance to cef ...... cter cloacae clinical isolate.
@ast
Extension of resistance to cef ...... cter cloacae clinical isolate.
@en
P2093
P1476
Extension of resistance to cef ...... cter cloacae clinical isolate.
@en
P2093
A Philippon
M J Sanson-Le Pors
P304
P356
10.1111/J.1574-6968.2001.TB10519.X
P577
2001-02-01T00:00:00Z